Canada markets closed

Zydus Lifesciences Limited (ZYDUSLIFE.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
1,084.00-5.10 (-0.47%)
At close: 03:29PM IST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
190,215,000
190,215,000
168,778,000
148,276,000
141,250,000
-
Cost of Revenue
62,282,000
62,282,000
63,101,000
58,189,000
50,708,000
-
Gross Profit
127,933,000
127,933,000
105,677,000
90,087,000
90,542,000
-
Operating Expenses
Research Development
-
-
1,358,000
1,146,000
1,250,000
897,000
Selling General and Administrative
-
-
21,401,000
18,014,000
18,125,000
18,968,000
Total Operating Expenses
82,541,000
82,541,000
77,149,000
65,320,000
63,168,000
-
Operating Income or Loss
45,392,000
45,392,000
28,528,000
24,767,000
27,374,000
-
Interest Expense
812,000
812,000
1,299,000
1,144,000
1,559,000
-
Income Before Tax
48,089,000
48,089,000
25,897,000
28,381,000
23,992,000
-
Income Tax Expense
9,775,000
9,775,000
5,878,000
5,117,000
1,936,000
-
Income from Continuing Operations
39,498,000
39,498,000
20,965,000
23,726,000
22,530,000
-
Net Income
38,365,000
38,365,000
19,649,000
44,873,000
21,336,000
-
Net Income available to common shareholders
38,365,000
38,365,000
19,649,000
44,873,000
21,336,000
-
Basic EPS
27.74
38.14
19.30
43.83
20.84
-
Diluted EPS
27.74
38.14
19.30
43.83
20.84
-
Basic Average Shares
1,012,012
1,005,899
1,018,083
1,023,743
1,023,743
-
Diluted Average Shares
1,012,012
1,005,899
1,018,083
1,023,743
1,023,743
-